维持性透析患者安全用药知信行现状调查及相关因素分析
|
魏珊, 纪鸥洋, 陈志豪, 黄泽慧, 李璞, 方均燕, 刘英莉
|
A prevalence study on knowledge, attitude, belief and practice of safe medication and analysis of related factors in dialysis patients
|
WEI Shan, JI Ouyang, CHEN Zhihao, HUANG Zehui, LI Pu, FANG Junyan, LIU Yingli
|
|
表2 维持性透析患者安全用药KAP得分的临床特征分析
|
Tab 2 Clinical characteristics analysis of KAP scores for safe medication in the maintenance dialysis patients
|
|
Indicator | n (%) | Score/ point | t/F value | P value |
---|
Dialysis pattern | | | -4.512 | 0.000 | MHD | 103 (55.08) | 72.26±14.61 | | | CAPD | 84 (44.92) | 83.32±20.64 | | | Dialysis age/month | | | 0.748 | 0.475 | <12 | 31 (16.58) | 80.42±19.32 | | | 12‒24 | 26 (13.90) | 79.88±21.74 | | | >24 | 130 (69.52) | 76.58±17.68 | | | Renal anemia | | | 2.021 | 0.045 | No | 18 (9.63) | 86.00±20.97 | | | Yes | 169 (90.37) | 76.79±18.09 | | | Renal osteodystrophy | | | 1.440 | 0.152 | No | 24 (12.83) | 82.75±22.04 | | | Yes | 163 (87.17) | 76.93±17.91 | | | Hypertension | | | 0.017 | 0.987 | No | 23 (12.30) | 77.74±17.56 | | | Yes | 164 (87.70) | 77.67±18.71 | | | Coronary heart disease | | | 1.178 | 0.240 | No | 99 (52.94) | 79.18±19.38 | | | Yes | 88 (47.06) | 75.99±17.48 | | | Diabetes mellitus | | | -0.726 | 0.469 | No | 134 (71.66) | 77.06±17.86 | | | Yes | 53 (28.34) | 79.25±20.21 | | |
|
|
|